Online CJC-1295

Research digest / sources

CJC-1295 References

Every quantitative claim on this site resolves to one of these studies, each with its PMID and DOI.

Back to the researchAbout this digest

How to read this list

The references below are the published CJC-1295 studies and the supporting GHRH-axis literature cited across this digest. The human pharmacokinetic core (Teichman 2006, Ionescu 2006) carries the GH/IGF-1 figures and the 5.8-8.1 day half-life; the foundational albumin-conjugate chemistry (Jette 2005) supplies the DAC mechanism; the animal proof-of-concept (Alba 2006) and the proteomic readout (Sackmann-Sala 2009) round out the primary record. The remaining entries supply class context and mechanism — the ghrelin/GHRH potentiation behind the ipamorelin pairing, the episodic-versus-continuous GHRH pulsatility point, and a 2025 Nature Reviews Endocrinology synthesis of the GHRH-analog class. Each citation lists its journal, year, PMID, and DOI so any figure can be checked at source.

  1. Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805. ↗
  2. Jette L, Leger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005;146(7):3052-3058. ↗
  3. Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006;91(12):4792-4797. ↗
  4. Sackmann-Sala L, Ding J, Frohman LA, Kopchick JJ. Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth Horm IGF Res. 2009;19(6):471-477. ↗
  5. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced GH secretion. Endocrinology. 2002. ↗
  6. Greater efficacy of episodic than continuous growth hormone-releasing hormone (GHRH) administration on GH release. J Clin Endocrinol Metab. 1996;81(3). ↗
  7. Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. Am J Physiol Endocrinol Metab. 2006;291(6):E1290-E1294. ↗
  8. Granata R, Leone S, Zhang X, Gesmundo I, et al. Growth hormone-releasing hormone and its analogues in health and disease. Nat Rev Endocrinol. 2025;21(3):180-195. ↗